“…Outside of the Orbitrap systems, the other main commercial option for FTMS is Bruker’s solariX platform, which offers 7, 12, and 15 T magnet options that provide >10 M resolving power and 0.6, 0.3, and 0.25 ppm mass accuracy, respectively. These instruments are Qq-FTICR instruments with the rf-only collision cell ( q ) having trapping capabilities for ETD fragmentation (including negative ETD), in addition to ion–electron activation (e.g., ECD, EDD, and niECD) in the ICR cell. − The solariX platform has also been modified for SID as well as UVPD and IRMPD activation, although these are not commercial options. ,− The performance of these instruments has been enhanced in recent years by introduction of the ParaCell ICR cell on the solariX XR and 2xR platforms, which ultimately improves resolving power for a given magnetic field and thus offers increased performance metrics even when magnetic field strength limitations cannot be overcome. , Additionally, a collaboration with government labs and several instrument companies (namely, Thermo and Bruker) has resulted in two world-record 21 T FTICR instruments that are accessible through collaboration programs. , Even though FTICR instruments have become increasingly less prevalent in proteomics research, they remain highly advantageous for intact protein and top-down analyses in addition to petroleomics, metabolomics, and other analyses that benefit from fine isotope structure determination. , …”